JPRN-jRCT2080221808未知2 期
Phase II study of ET-743 in patients with translocation-related sarcomas
试验速览
- 阶段
- 2 期
- 入组人数
- 74
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 19age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Any of TRS histopathologically confirmed at the study site
- •- Unresponsiveness or intolerability to the standard chemotherapy regimens
排除标准
- •- Severe concurrent disease
研究者
相似试验
未知
2 期
Safety study of ET-743 in patients with translocation-related sarcomasJPRN-jRCT2080221811Taiho Pharmaceutical Co., Ltd.37
未知
2 期
Safety assessment study of ET-743 in patients with translocation-related sarcomasPatients with malignant soft tissue sarcomas of histological types that have been reported to carry chromosomal translocationsJPRN-jRCT2080222464Taiho Pharmaceutical Co., Ltd.50
进行中（未招募）
3 期
Clinical study on PTC743 in Patients with Leigh's Encephalomyelopathy (Continued Dosing Study)eigh's encephalomyelopathyJPRN-jRCT2031200224Penematsa Vinay12
未知
2 期
Early phase II clinical study with AT-877ER in patients with pulmonary arterial hypertensioPulmonary arterial hypertensionJPRN-jRCT2080220801ASAHI KASEI PHARMA CORPORATIO
未知
2 期
Double-blind, Phase2 Study of TS-071 in Patients With Type 2 Diabetes Mellitus (Confirmatory Study of Dose-Response)Type 2 Diabetes MellitusJPRN-jRCT2080221156Taisho Pharmaceutical co., LTD275